A Maternal Vaccine Against Group B Streptococcus: Past, Present, and Future

Overview

Journal Vaccine

Specialty Allergy & Immunology

Date 2013 Aug 27

PMID 23973342

Citations 34

Authors

Vincent L Chen

Fikri Y Avci

Dennis L Kasper

Affiliations

Soon will be listed here.

Abstract

Group B Streptococcus (GBS) is a major cause of morbidity and mortality among neonates. Though there have been tremendous advances in prevention of invasive neonatal GBS disease through prophylactic antibiotic treatment of pregnant women, the incidence of neonatal disease has not changed significantly over the past several years. Vaccination of pregnant women is an important strategy that has the potential to improve further on existing protocols. In this review, we explore the history of the design of maternal GBS vaccines. We also discuss how recent applications of genomics and immunology to vaccine design promise to further enhance our ability to develop more effective vaccines against this important disease.

Citing Articles

Acceptance and uptake of vaccines against tetanus, influenza, pertussis, and COVID-19 among pregnant and postpartum women in low- and middle-income countries: a systematic review and meta-analysis protocol.

Ayouni I, Mbangiwa T, Amponsah-Dacosta E, Noll S, Kagina B, Muloiwa R Syst Rev. 2024; 13(1):227.

PMID: 39237969 PMC: 11375862. DOI: 10.1186/s13643-024-02645-7.

Using Surface Immunogenic Protein as a Carrier Protein to Elicit Protective Antibody to Multiple Serotypes for Candidate Group B Streptococcal Glycan Conjugate Vaccines.

Duan H, Huang W, Lv Q, Liu P, Li Q, Kong D Vaccines (Basel). 2024; 12(6).

PMID: 38932301 PMC: 11209137. DOI: 10.3390/vaccines12060573.

Immune responses against group B monovalent and pentavalent capsular polysaccharide tetanus toxoid conjugate vaccines in Balb/c mice.

Dhar N, Mohamed E, Kirstein F, Williams M, Dorasamy S, van Zyl P iScience. 2023; 26(8):107380.

PMID: 37575182 PMC: 10415928. DOI: 10.1016/j.isci.2023.107380.

Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines.

Rohokale R, Guo Z ACS Infect Dis. 2023; 9(2):178-212.

PMID: 36706246 PMC: 9930202. DOI: 10.1021/acsinfecdis.2c00559.

Group B Streptococcus: Virulence Factors and Pathogenic Mechanism.

Liu Y, Liu J Microorganisms. 2022; 10(12).

PMID: 36557736 PMC: 9784991. DOI: 10.3390/microorganisms10122483.

References

Slotved H, Kong F, Lambertsen L, Sauer S, Gilbert G . Serotype IX, a Proposed New Streptococcus agalactiae Serotype. J Clin Microbiol. 2007; 45(9):2929-36. PMC: 2045254. DOI: 10.1128/JCM.00117-07. View

Kasper D, Baker C, Galdes B, Katzenellenbogen E, Jennings H . Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide. J Clin Invest. 1983; 72(1):260-9. PMC: 1129181. DOI: 10.1172/jci110965. View

Carlin A, Chang Y, Areschoug T, Lindahl G, Hurtado-Ziola N, King C . Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. J Exp Med. 2009; 206(8):1691-9. PMC: 2722167. DOI: 10.1084/jem.20090691. View

Wessels M, Rubens C, Benedi V, Kasper D . Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc Natl Acad Sci U S A. 1989; 86(22):8983-7. PMC: 298416. DOI: 10.1073/pnas.86.22.8983. View

Baker C, Edwards M . Group B streptococcal conjugate vaccines. Arch Dis Child. 2003; 88(5):375-8. PMC: 1719562. DOI: 10.1136/adc.88.5.375. View

Thigpen M, Whitney C, Messonnier N, Zell E, Lynfield R, Hadler J . Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011; 364(21):2016-25. DOI: 10.1056/NEJMoa1005384. View

Kasper D, Paoletti L, Wessels M, Guttormsen H, Carey V, Jennings H . Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest. 1996; 98(10):2308-14. PMC: 507681. DOI: 10.1172/JCI119042. View

Borchardt S, DeBusscher J, Tallman P, Manning S, Marrs C, Kurzynski T . Frequency of antimicrobial resistance among invasive and colonizing Group B streptococcal isolates. BMC Infect Dis. 2006; 6:57. PMC: 1435911. DOI: 10.1186/1471-2334-6-57. View

Avci F, Li X, Tsuji M, Kasper D . Isolation of carbohydrate-specific CD4(+) T cell clones from mice after stimulation by two model glycoconjugate vaccines. Nat Protoc. 2012; 7(12):2180-92. PMC: 4133772. DOI: 10.1038/nprot.2012.138. View

10.

Palmeira P, Quinello C, Silveira-Lessa A, Zago C, Carneiro-Sampaio M . IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol. 2012; 2012:985646. PMC: 3251916. DOI: 10.1155/2012/985646. View

11.

Stevens J, Eames M, Kent A, Halket S, Holt D, Harvey D . Long term outcome of neonatal meningitis. Arch Dis Child Fetal Neonatal Ed. 2003; 88(3):F179-84. PMC: 1721546. DOI: 10.1136/fn.88.3.f179. View

12.

. Group B streptococcal infections in pregnancy. ACOG Technical Bulletin Number 170--July 1992. Int J Gynaecol Obstet. 1993; 42(1):55-9. View

13.

Fluegge K, Siedler A, Heinrich B, Schulte-Moenting J, Moennig M, Bartels D . Incidence and clinical presentation of invasive neonatal group B streptococcal infections in Germany. Pediatrics. 2006; 117(6):e1139-45. DOI: 10.1542/peds.2005-2481. View

14.

Dagnew A, Cunnington M, Dube Q, Edwards M, French N, Heyderman R . Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis. 2012; 55(1):91-102. DOI: 10.1093/cid/cis395. View

15.

Duan J, Avci F, Kasper D . Microbial carbohydrate depolymerization by antigen-presenting cells: deamination prior to presentation by the MHCII pathway. Proc Natl Acad Sci U S A. 2008; 105(13):5183-8. PMC: 2278222. DOI: 10.1073/pnas.0800974105. View

16.

Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A . Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002; 51(RR-11):1-22. View

17.

Sendi P, Johansson L, Norrby-Teglund A . Invasive group B Streptococcal disease in non-pregnant adults : a review with emphasis on skin and soft-tissue infections. Infection. 2008; 36(2):100-11. DOI: 10.1007/s15010-007-7251-0. View

18.

Kadioglu A, Weiser J, Paton J, Andrew P . The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol. 2008; 6(4):288-301. DOI: 10.1038/nrmicro1871. View

19.

Baker C, Kasper D . Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med. 1976; 294(14):753-6. DOI: 10.1056/NEJM197604012941404. View

20.

Lauer P, Rinaudo C, Soriani M, Margarit I, Maione D, Rosini R . Genome analysis reveals pili in Group B Streptococcus. Science. 2005; 309(5731):105. DOI: 10.1126/science.1111563. View